Friday, October 18

EANO Meeting - Friday, October 18, 2024

Note that the programme is subject to change and will be continuously updated.
All times below refer to British Summer Time (BST).

08:00-09:00 hrs

Chairs: tbc

ME01.1 Clarification on the WHO Classification 2021
Pieter Wesseling, Netherlands

ME01.2 New Tumor Types
Cynthia Hawkins, Canada

ME01.3 Use of methylation profiling
Pascale Varlet, France

Chairs: tbc

ME02.1 Neuro-Oncology Journal
Susan Chang, United States

ME02.2 Neuro-Oncology Advances Journal
Gelareh Zadeh, Canada

ME02.3 Neuro-Oncology Practice Journal
Martin Taphoorn, Netherlands

Chair: tbc

ME03.1 Neuro-oncological Patient and Caregiver Advisory Group in a Proton therapy dose finding trial
Anouk Kirsten Trip, Denmark

ME03.2 How to measure the effect from PPI in research- The Patient Engagement In Research Scale (PEIRS-22)
Clayon Hamilton, Canada

ME03.3 The impact of patient involvement in neuro oncological research
Helen Bulbeck, United Kingdom

09:00-09:15 hrs | BREAK

09:15-10:45 hrs

Chairs: tbc

JS02.1 Interplay between DDR and immune response in glioma
Maria Castro, United States

JS02.2 Early phase clinical trials of DDR inhibitors in glioblastoma-state of play
Anthony Chalmers, United Kingdom

JS02.3 Neuro- and radioprotective effects of DDR inhibitors in brain tumour patients
Kaye Williams, United Kingdom

JS02.4 Exploiting MGMT and other DNA repair deficiencies in glioma to induce tumour specific DNA damage
Ranjit S. Bindra, United States

Chairs: tbc

KS01.1 Boosting immunity using radiotherapy
Kathryn Beal, United States

KS01.2 Gut-brain axis in glioblastoma
Francisco Quintana, United States

KS01.3 Diet, microbiome and immunity
Anne-Katrin Pröbstel, Switzerland

Chairs: tbc

OS02.1 Psychological therapies for symptom control
Martin Klein, Netherlands

OS02.2 Exercise for symptom management
Karin Gehring, Netherlands

OS02.3 Carer preparedness for carers of patients with high-grade glioma: RCT results
Georgia Halkett, Australia

Chairs: Philipp Lohmann, Matthijs van der Meulen, Dan Mitrea

WS01.1 Introduction of CBI
Marjolein Geurts, Netherlands

WS01.2 Charting the Path to Independence: What can EANO do for you?
Susan Short, United Kingdom

WS01.3 Time management – Tips and Tricks to Combine Clinical and research duties
Michael Platten, Germany

WS01.4 People management – Effective Student Mentoring
Matthias Preusser, Austria

WS01.5 Introduction of knowledge market
Johnny Duerinck, Belgium

WS01.5.A Molecular pathology/The Heidelberg classifier
Abigail Suwala, Germany

WS01.5.B Storage and processing of large datasets
Philipp Vollmuth, Germany

WS01.5.C Mouse models for glioma research
Leila Akkari, Netherlands

WS01.5.D Neurosurgical trials in oncology
Asgeir Jakola, Sweden




10:45-11:15 hrs | COFFEE BREAK

11:15-13:15 hrs

Susan Short, United Kingdom
President EANO

Anthony Chalmers, United Kingdom
President EANO Meeting 2024

Manuel Valiente, Spain
Chair EANO Scientific Committee

Chairs: tbc

PL01.1 A framework for understanding white matter invasion
Francesco Latini, Sweden

PL01.2 Functional connectivity following treatment of brain tumors
Linda Douw, Netherlands

PL01.3 Remote neuronal activity promotes glioblastoma progression and brain network hyperactivity
Benjamin Deneen, United States

13:15-14:45 hrs | LUNCH BREAK

13:30-14:30 hrs

14:45-16:15 hrs

Chairs: tbc

KS02.1 Overview, update and recent findings of the INDIGO trial
Patrick Wen, United States

KS02.2 The role of IDH inhibitors in relation to standard of care  for IDH mutated gliomas
Martin van den Bent, Netherlands

KS02.3 Effects of IDH inhibitors on quality of life and seizure control
Katherine Peters, United States

KS02.4 Molecular and cellular effects of IDH inhibitors
Marc Sanson, France

Chairs: tbc

OS03.1 Vulnerabilities of dormant/ latent cancer cells
Srinivas Malladi, United States

OS03.2 Vulnerabilities of senescent cancer cells
Isabelle Le Roux, France

OS03.3 Senolytic drug development
Terry Burns, United States

Chairs: tbc

OS04.1 The hormone-sensitivity of glioma and the question of pregnancy
Héléne Dumond, France

OS04.2 Navigating Parenthood: Challenges of Living with a Brain Tumor
Emma Nicklin, United Kingdom

OS04.3 Fertility preservation in women with CNS tumors
Alicia Tosoni, Italy

OS04.4 Fertility, a brain tumour and me
Shona Floyd, United Kingdom

16:15-16:30 hrs | BREAK

16:30-18:00 hrs

Chairs: tbc

JS03.1 Targeted therapies in pediatric brain tumors paving the way for adult patients
Marcel Kool, Netherlands

JS03.2 Molecular testing and treatment of young adults with CNS tumors
Angela Mastronuzzi, Italy

JS03.3 Late toxicity and long term morbidity in adult survivors of a CNS tumor during childhood or adolescence
Katrin Scheinemann, Switzerland

JS03.4 Pediatric-type brain tumors in adults
Peter Hau, Germany

Chairs: tbc

JS04.1 Lessons learned from ReSurge
Philippe Schucht, Switzerland

JS04.2 Ethics of randomisation in the field of surgery
Marike Broekman, Netherlands

JS04.3 What can surgery learn from other disciplines in terms of trial design?
Roberta Ruda, Italy

Chairs: tbc

WS02.1 Group A: Clinical trial Editor
Ulrike Harjes, United Kingdom (Nature Medicine)

WS02.2 Group A: Clinical trial Researcher
Michael Weller, Switzerland

WS02.3 Group B: Basic science Editor
Alexia-Ileana Zaromytidou, United States (Nature Cancer)

WS02.4 Group B: How to publish successfully: The perspective of a basic science researcher
Michael Platten, Germany

WS02.5 Group C: How to publish: The editor’s perspective on translational science
Sara Hamilton, United States (Cell reports Medicine)

WS02.6 Group C: How to publish successfully: The perspective of a translational science researcher
Mariella Filbin, United States

WS02.7 Group D: How to publish: The editor’s perspective on translational science
Kathy Miller, United States (JCO)

WS02.8 Group D: How to publish: The scientist’s perspective on translational science
Emeline Tabouret, France

WS02.9 Group E: How to write grants successfully
Susan Chang, United States (Neuro-Oncology)

WS02.10 Group E: How to write grants successfully: The perspective of a researcher
Dieter Henrik Heiland, Germany

18:00-19:30 hrs

Poster Viewing with authors I

20:00 hrs | Networking Events

EANO Youngsters, CBI and NAC Networking Events